Physician profile
William C Ackerman
NPI 1548303993
$4,470.77
in general payments reported to CMS, 2019-2025
18 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $667 · 2021: $987 · 2022: $840 · 2023: $495 · 2024: $450 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.79 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,329.73 | 2019-2025 | Clareon, Lensx, Ngenuity |
| Sun Pharmaceutical Industries INC. | $1,171.17 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $696.40 | 2019-2021 | |
| Allergan, INC. | $265.07 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $260.43 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Oyster Point Pharma, INC. | $200.95 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $99.75 | 2019-2021 | |
| Acera Surgical, INC. | $90.35 | 2024 | Restrata Wound Matrix |
| Johnson & Johnson Surgical Vision, INC. | $71.09 | 2019-2025 | Tecnis Iol, Tecnis Simplicity |
| Tarsus Pharmaceuticals, INC. | $66.24 | 2024-2025 | Xdemvy |
| Abbvie INC. | $52.47 | 2023-2024 | Vuity, Lumigan, Alphagan P |
| Astellas Pharma US INC | $44.56 | 2025 | Izervay |
| Harrow Eye, LLC | $41.45 | 2024-2025 | Triesence, Vevye |
| Eyepoint US, INC. | $20.12 | 2019 | |
| Shire North American Group INC | $17.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $16.90 | 2019 | |
| Dompe US, INC. | $13.92 | 2022 | |
| Omeros Corporation | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.